Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bone Therapeutics SA (BR: BOTHE)

 
BOTHE Technical Analysis
5
As on 26th Oct 2022 BOTHE STOCK Price closed @ 0.29 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.35 & Strong Sell for SHORT-TERM with Stoploss of 2.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BOTHESTOCK Price

Open 0.19 Change Price %
High 0.30 1 Day 0.12 70.59
Low 0.19 1 Week 0.14 93.33
Close 0.29 1 Month 0.06 26.09
Volume 1382977 1 Year -2.23 -88.49
52 Week High 2.72 | 52 Week Low 0.13
 
BR Belgium Most Active Stocks
ABI 52.58 0.65%
BOTHE 0.29 70.59%
ACPH 0.89 0.00%
UMI 10.31 1.58%
AGFB 0.67 3.08%
KBC 68.70 -1.24%
WDP 20.72 2.98%
PROX 6.72 0.30%
BPOST 1.95 0.52%
UCB 180.00 3.36%
 
BR Belgium Top Gainers Stocks
BOTHE 0.29 70.59%
INCLU 14.55 7.78%
GIMB 40.85 5.42%
CFEB 6.05 4.31%
IBAB 13.74 4.09%
DIE 204.80 4.07%
DIE 204.80 4.07%
DIE 204.80 4.07%
DIE 204.80 4.07%
DIE 204.80 4.07%
 
BR Belgium Top Losers Stocks
BELR 1.93 -74.27%
BELR 1.93 -74.27%
NEWT 1.80 -9.55%
NEWT 1.80 -9.55%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
ZEN 185.00 -4.64%
ZEN 185.00 -4.64%
ZEN 185.00 -4.64%
 
 
BOTHE
Daily Charts		 BOTHE
Intraday Charts		 Whats New @
Bazaartrend		 BOTHE
Free Analysis
 
BOTHE Important Levels Intraday
RESISTANCE0.50
RESISTANCE0.43
RESISTANCE0.39
RESISTANCE0.35
SUPPORT0.23
SUPPORT0.19
SUPPORT0.15
SUPPORT0.08
 
BOTHE Forecast November 2024
Share
4th UP Forecast1.1
3rd UP Forecast0.84
2nd UP Forecast0.68
1st UP Forecast0.52
1st DOWN Forecast0.06
2nd DOWN Forecast-0.1
3rd DOWN Forecast-0.26
4th DOWN Forecast-0.52
 
BOTHE Weekly Forecast
4th UP Forecast0.91
3rd UP Forecast0.71
2nd UP Forecast0.59
1st UP Forecast0.46
1st DOWN Forecast0.12
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.13
4th DOWN Forecast-0.33
 
BOTHE Forecast2024
4th UP Forecast5.4
3rd UP Forecast3.76
2nd UP Forecast2.75
1st UP Forecast1.73
1st DOWN Forecast-1.15
2nd DOWN Forecast-2.17
3rd DOWN Forecast-3.18
4th DOWN Forecast-4.82
 
 
BOTHE Other Details
Segment EQ
Market Capital 21751224.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BOTHE Address
BOTHE
 
BOTHE Latest News
 
Your Comments and Response on Bone Therapeutics SA
 
BOTHE Business Profile
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa studies for the treatment of delayed-union fractures and lumbar spinal fusion. The company is also developing JTA-004, an intra-articular injectable, which is in phase III development for the treatment of osteoarthritic pain in the knee. Bone Therapeutics SA has collaborations with Cerhum, 3D-Side, mSKIL, and IREC to develop personalized, tissue engineered bone implants; and a research partnership with Implant Therapeutics to access induced pluripotent stem cells. The company was incorporated in 2006 and is based in Gosselies, Belgium. Address: rue Auguste Piccard, 37, Gosselies, Belgium, 6041
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service